Market Value2,921,575,681
Total Holdings64
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PRTA / Prothena Corporation plc
BBIO / BridgeBio Pharma, Inc.
NUVB / Nuvation Bio Inc.
ANAB / AnaptysBio, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
AVIR / Atea Pharmaceuticals, Inc.
MORF / Morphic Holding, Inc.
CLDX / Celldex Therapeutics, Inc.
KYTX / Kyverna Therapeutics, Inc.
ARVN / Arvinas, Inc.
ALVR / AlloVir, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
RNA / Avidity Biosciences, Inc.
ETON / Eton Pharmaceuticals, Inc. Call
TECX / Tectonic Therapeutic, Inc.
NGNE / Neurogene Inc.
JANX / Janux Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
PRME / Prime Medicine, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
WHWK / Whitehawk Therapeutics, Inc.
ARTV / Artiva Biotherapeutics, Inc.
ALGS / Aligos Therapeutics, Inc.
HOOK / HOOKIPA Pharma Inc.
SRPT / Sarepta Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
THRD / Third Harmonic Bio, Inc.
PCVX / Vaxcyte, Inc.
RLAY / Relay Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
KROS / Keros Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
ALLK / Allakos Inc.
HOOK / HOOKIPA Pharma Inc.
VYGR / Voyager Therapeutics, Inc.
LENZ / LENZ Therapeutics, Inc.
PRQR / ProQR Therapeutics N.V.
EWTX / Edgewise Therapeutics, Inc.
CRGX / CARGO Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
GBIO / Generation Bio Co.
MDGL / Madrigal Pharmaceuticals, Inc.
REPL / Replimune Group, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
CRSP / CRISPR Therapeutics AG
JAZZ / Jazz Pharmaceuticals plc
TCRX / TScan Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
CMAXW / CareMax Inc - Warrants (08/06/2026)
RCKT / Rocket Pharmaceuticals, Inc.
ATRA / Atara Biotherapeutics, Inc.
ETON / Eton Pharmaceuticals, Inc.
ZYME / Zymeworks Inc.
PHVS / Pharvaris N.V.
KURA / Kura Oncology, Inc.
IMNM / Immunome, Inc.
MGNX / MacroGenics, Inc.
NMRA / Neumora Therapeutics, Inc.
XNCR / Xencor, Inc.
MBX / MBX Biosciences, Inc.
DSGN / Design Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
ALGS / Aligos Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
ITOS / iTeos Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.